Profile data is unavailable for this security.
About the company
Lepu Biopharma Co Ltd is a company principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The Company is focused on oncology therapeutics, in particular, targeted therapy and oncology immunotherapy. The Company is dedicated to developing innovative antibody-drug conjugate (ADC) through an ADC technology development platform. The Company’s clinical-stage drug candidates cover targeted therapeutics and an immunotherapeutic, including MRG003, MRG002, CMG901, MRG004A, CG0070, MRG006A, MRG007, and CTM012.
- Revenue in HKD (TTM)796.00m
- Net income in HKD-201.37m
- Incorporated2018
- Employees546.00
- LocationLepu Biopharma Co LtdNo. 651, Lianheng Road, Minhang DistrictSHANGHAI 201114ChinaCHN
- Phone+86 2 167696099
- Websitehttps://www.lepubiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qyuns Therapeutics Co Ltd | 364.06m | -217.95m | 3.70bn | 337.00 | -- | 14.24 | -- | 10.17 | -0.9813 | -0.9813 | 1.64 | 1.16 | 0.2903 | 4.05 | 9.14 | 1,073,926.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| TYK Medicines Inc | 121.60k | -318.29m | 4.10bn | 163.00 | -- | 9.87 | -- | 33,756.94 | -0.8583 | -0.8583 | 0.0003 | 1.09 | 0.0002 | -- | -- | 794.75 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 228.84m | -51.88m | 4.37bn | 211.00 | -- | 4.44 | -- | 19.08 | -0.067 | -0.067 | 0.2958 | 1.25 | 0.1547 | -- | 7.97 | 890,433.90 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| MiRXES Holding Co Ltd | -100.00bn | -100.00bn | 4.55bn | 347.00 | -- | 5.10 | -- | -- | -- | -- | -- | 2.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.83 | -- | 0.1682 | -- | -16.14 | -- | -33.37 | -- | -- | -- |
| Laekna Inc | 0.00 | -273.00m | 5.02bn | 84.00 | -- | 5.66 | -- | -- | -0.7423 | -0.7423 | 0.00 | 1.99 | 0.00 | -- | -- | 0.00 | -27.79 | -- | -34.25 | -- | -- | -- | -- | -- | -- | -- | 0.1383 | -- | -- | -- | 31.05 | -- | -- | -- |
| Edding Genor Group Holdings Ltd | 254.56m | 22.89m | 5.12bn | 17.00 | 56.76 | 1.08 | 146.75 | 20.12 | 0.0451 | 0.0451 | 0.4902 | 2.38 | 0.1724 | -- | 5.21 | 10,606,700.00 | 1.46 | -48.63 | 1.72 | -55.19 | 99.56 | 97.88 | 8.45 | -2,303.07 | -- | -- | 0.0007 | -- | -- | 73.71 | 92.40 | -- | -43.79 | -- |
| CARsgen Therapeutics Holdings Ltd | 95.51m | -593.11m | 6.95bn | 371.00 | -- | 6.42 | -- | 72.73 | -1.08 | -1.08 | 0.1736 | 1.90 | 0.0465 | 5.13 | 7.63 | 204,083.10 | -28.88 | -76.51 | -32.44 | -89.25 | 50.57 | -- | -621.16 | -12,640.86 | 6.40 | -- | 0.0672 | -- | -- | -- | -6.73 | -- | -28.32 | -- |
| Lepu Biopharma Co Ltd | 796.00m | -201.37m | 7.36bn | 546.00 | -- | 8.24 | -- | 9.25 | -0.1177 | -0.1177 | 0.4653 | 0.4951 | 0.2917 | 2.35 | 18.33 | 1,598,400.00 | -8.24 | -24.70 | -14.39 | -37.71 | 88.41 | -- | -28.26 | -459.37 | 0.5915 | -5.03 | 0.5632 | -- | 63.21 | -- | -1,761.77 | -- | -29.86 | -- |
| Abbisko Cayman Ltd | 695.62m | 62.78m | 7.50bn | 220.00 | 127.77 | 3.43 | 19.40 | 10.78 | 0.0873 | 0.0873 | 1.10 | 3.25 | 0.2745 | -- | -- | 3,161,906.00 | 2.48 | -24.40 | 2.83 | -25.96 | 100.00 | 100.00 | 9.03 | -229.19 | -- | -- | 0.1363 | -- | 21.45 | -- | 95.21 | -- | -- | -- |
| Alphamab Oncology | 893.17m | 264.57m | 7.68bn | 484.00 | 30.08 | 3.61 | 22.22 | 8.60 | 0.2636 | 0.2636 | 0.8975 | 2.20 | 0.3492 | 0.8254 | 23.76 | 2,126,606.00 | 10.35 | -9.96 | 12.30 | -11.75 | 92.27 | -- | 29.62 | -103.28 | 4.75 | -- | 0.1285 | -- | 192.58 | -- | 178.99 | -- | -33.81 | -- |
| GenFleet Therapeutics (Shanghai) Inc | 219.84m | -1.05bn | 9.27bn | 94.00 | -- | -- | -- | 42.19 | -3.05 | -3.05 | 0.6366 | -8.69 | -- | -- | -- | -- | -- | -- | -- | -- | 80.86 | -- | -479.17 | -- | 0.1655 | -23.43 | -- | -- | 42.00 | -- | -33.31 | -- | -- | -- |
| Suzhou Ribo Life Science Co Ltd | 204.71m | -250.84m | 10.40bn | 404.00 | -- | -- | -- | 50.82 | -1.55 | -1.55 | 1.27 | -0.4107 | -- | -- | -- | -- | -- | -- | -- | -- | 90.90 | -- | -131.95 | -- | 0.9173 | -14.93 | 0.8949 | -- | 324,052.30 | -- | 36.93 | -- | -- | -- |
| Nanjing Leads Biolabs Co Ltd | 0.00 | -326.39m | 10.86bn | 192.00 | -- | 86.38 | -- | -- | -2.01 | -2.01 | 0.00 | 0.632 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.01 | -- | 0.7407 | -- | -100.00 | -- | 16.85 | -- | -- | -- |
Data as of Mar 04 2026. Currency figures normalised to Lepu Biopharma Co Ltd's reporting currency: Hong Kong Dollar HKD
5.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 19.55m | 1.08% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 12.01m | 0.67% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 9.59m | 0.53% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 9.58m | 0.53% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 9.50m | 0.53% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2025 | 8.28m | 0.46% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 7.30m | 0.41% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 5.94m | 0.33% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 4.91m | 0.27% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 3.90m | 0.22% |
More ▼
Data from 30 Jun 2025 - 20 Feb 2026Source: FactSet Research Systems Inc.
